Janus Henderson Group
TMCI icon

Janus Henderson Group’s Treace Medical Concepts TMCI Stock Holding History

Janus Henderson Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,553
Closed -$113K – 2576
2024
Q3 		$113K Hold
19,553
– – ﹤0.01% 2504
2024
Q2 		$130K Sell
19,553
-226
-1% -$1.83K ﹤0.01% 2478
2024
Q1 		$258K Buy
19,779
+3
+0% +$40 ﹤0.01% 2294
2023
Q4 		$252K Sell
19,776
-33
-0.2% -$333 ﹤0.01% 2326
2023
Q3 		$260K Buy
19,809
+13
+0.1% +$238 ﹤0.01% 2260
2023
Q2 		$506K Buy
19,796
+11,307
+133% +$292K ﹤0.01% 1969
2023
Q1 		$214K Sell
8,489
-534,791
-98% -$12.6M ﹤0.01% 2460
2022
Q4 		$12.5M Sell
543,280
-121,266
-18% -$2.79M 0.01% 671
2022
Q3 		$14.7M Sell
664,546
-105
-0% -$2.03K 0.01% 607
2022
Q2 		$9.53M Sell
664,651
-1,761
-0.3% -$29.7K 0.01% 702
2022
Q1 		$12.6M Buy
666,412
+63
+0% +$1.23K 0.01% 848
2021
Q4 		$12.4M Buy
666,349
+10,423
+2% +$215K 0.01% 881
2021
Q3 		$17.6M Sell
655,926
-16,633
-2% -$458K 0.01% 821
2021
Q2 		$21M Buy
+672,559
New +$21.4M 0.01% 776

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Janus Henderson Group's TMCI Position: Q4 2024 in Review

Janus Henderson Group sold out of Treace Medical Concepts (TMCI) in Q4 2024, closing a stake of 19,553 shares — an estimated $113K sold.

Janus Henderson Group first reported a position in TMCI in Q2 2021 and held it in 14 quarters. The position peaked at $21M in Q2 2021. 135 funds tracked by Wall St. Rank hold TMCI as of Q4 2024.

  • Janus Henderson Group reported no remaining Treace Medical Concepts position as of Q4 2024 after selling out during the quarter.
  • Janus Henderson Group sold 19,553 Treace Medical Concepts shares in Q4 2024, an estimated $113K.
  • Janus Henderson Group first reported a position in Treace Medical Concepts in Q2 2021 and held it in 14 quarters.
  • Janus Henderson Group's Treace Medical Concepts position peaked at $21M in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2024.

Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.